Dergiler / Marmara Pharmaceutical Journal / 2018 / Cilt: 22 - Sayı: 4

Investigating the physicochemical properties of phenazopyridine hydrochloride using high-performance liquid chromatography and UV-visible spectrophotometry

Sayfa
528–535
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The pKa, log P, and log D values of PHCl can be determined by HPLC and UV-Vis spectrophotometry with reproducible results.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The purpose of this study is to develop high-performance liquid chromatography (HPLC) and ultravioletvisible (UV-Vis) spectrophotometry methods for the determination of pKa, log P, and log D values of phenazopyridine hydrochloride (PHCl).
📊
Temel Bulgular & Veri:Meanwhile, for the UV-Vis spectrophotometric study, the absorbance of PHCl was plotted against pH at 332 nm to obtain the pKa value.
💡
Sonuç & Katkı:The pKa, log P, and log D values of PHCl can be determined by HPLC and UV-Vis spectrophotometry with reproducible results.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

The purpose of this study is to develop high-performance liquid chromatography (HPLC) and ultravioletvisible (UV-Vis) spectrophotometry methods for the determination of pKa, log P, and log D values of phenazopyridine hydrochloride (PHCl). For the HPLC analysis, the pH of the mobile phase was plotted against the capacity factor, and the pKa value was obtained from a sigmoidal relationship. Meanwhile, for the UV-Vis spectrophotometric study, the absorbance of PHCl was plotted against pH at 332 nm to obtain the pKa value. The log P and log D (at pH 2.0) values were then calculated based on the concentration of PHCl in the octanol/water phase. Using the HPLC method, the pKa value was established as 5.05 (± 0.15). Meanwhile, the spectroscopic technique afforded pKa values of 5.20 (± 0.22) and 5.17 (± 0.17) via a classical sigmoidal curve and the Albert and Serjeant method. The log D (at pH 2.0) and log P values of PHCl were 1.61 (± 0.16) and 2.62 (± 0.11), respectively. The obtained results are in good agreement with each other. The pKa, log P, and log D values of PHCl can be determined by HPLC and UV-Vis spectrophotometry with reproducible results.

🔖

Bu Makaleye Atıf Yap

ÇELEBİER, M., KOÇAK, E., DOĞAN, A., ALTINÖZ, S., BAŞCI, N. E. (2018). Investigating the physicochemical properties of phenazopyridine hydrochloride using high-performance liquid chromatography and UV-visible spectrophotometry. Marmara Pharmaceutical Journal, Cilt: 22 - Sayı: 4, 528–535. https://ajindex.com/articles/283738

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Smith DA, Allerton C, Kalgutkar AS, Waterbeemd H, Walker DK, Pharmacokinetics and Metabolism in Drug Design, Weinheim: Wiley-VCH, USA 2012
  2. Ritschel WA, Kearns GL, Handbook of Basic Pharmacokinetics - Including Clinical Applications, Washington, DC: American Pharmacists Association, USA 2004
  3. Avdeef A, Testa B. Physicochemical Profiling in Drug Research: A Brief Survey of the State-of-the-Art of Experimental Techniques. Cell Mol Life Sci. 2002; 59 (10): 1681-1689
  4. Alanne AL, Hyvonen H, Lahtinen M, Ylisirnio M, Turhanen P, Kolehmainen E, Peraniemi S, Vepsalainen J. Systematic Study of the Physicochemical Properties of a Homologous Series of Aminobisphosphonates. Molecules. 2012; 17 (9): 10928-10945
  5. Box KJ, Volgyi G, Ruiz R, Comer JE, Takacs-Novak K, Bosch E, Rafols C, Roses M. Physicochemical Properties of a New Multicomponent Cosolvent System for the pK(a) Determination of Poorly Soluble Pharmaceutical Compounds. Helv Chim Acta. 2007; 90 (8): 1538-1553
  6. Fu XC, Liang WQ, Ma WX. Relationships Between the Release of Soluble Drugs from HPMC Matrices and the Physicochemical Properties of Drugs. Pharmazie. 2003; 58(3): 221-222
  7. Schmitt-Willich H, Brehm M, Ewers CLJ, Michl G, Muller-Fahrnow A, Petrov O, Platzek J, Raduchel B, Sulzle D. Synthesis and Physicochemical Characterization of a New Gadolinium Chelate: The liver-specific Magnetic Resonance İmaging Contrast Agent Gd-EOB-DTPA. Inorg Chem. 1999; 38 (6): 1134-1144
  8. Ho NF, Sims SM, Vidmar TJ, Day JS, Barsuhn CL, Thomas EM, Geary TG, Thompson DP. Theoretical Perspectives on Anthelmintic Drug Discovery: Interplay of Transport Kinetics, Physicochemical Properties, and in vitro Activity of Anthelmintic Drugs. J Pharm Sci. 1994; 83 (7): 1052-1059
  9. Lee PH, Ayyarnpalayarn SN, Carreira LA, Shalaeva M, Bhattachar S, Coselmon R, Poole S, Gifford E, Lombardo F. In silico Prediction of Ionization Constants of Drugs. Mol Pharm. 2007; 4 (4): 498-512
  10. Ekins S, Mestres J, Testa B. In silico Pharmacology for Drug discovery: Applications to Targets and Beyond. Brit J Pharmacol. 2007; 152 (1): 21-37
  11. Ramsay AG. Clinical Application of the Henderson-Hasselbalch Equation. Appl Ther. 1965; 7 (9): 730-736
  12. Merck Manual, Overview of Pharmacokinetics. http://www.merckmanuals.com (accessed Sep 8, 2015)
  13. Food and Drug Administration, FDA. Available from: http://www.fda.gov (accessed Sep 8, 2015)
  14. Van de Waterbeemd H. The Fundamental Variables of the Biopharmaceutics Classific